These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21269131)

  • 1. Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa.
    Chaiyachati K; Hirschhorn LR; Tanser F; Newell ML; Bärnighausen T
    AIDS Patient Care STDS; 2011 Mar; 25(3):163-70. PubMed ID: 21269131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems.
    Erb S; Letang E; Glass TR; Natamatungiro A; Mnzava D; Mapesi H; Haschke M; Duthaler U; Berger B; Muri L; Bader J; Marzolini C; Elzi L; Klimkait T; Langewitz W; Battegay M;
    HIV Med; 2017 Oct; 18(9):623-634. PubMed ID: 28296019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
    Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
    Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.
    Boullé C; Kouanfack C; Laborde-Balen G; Boyer S; Aghokeng AF; Carrieri MP; Kazé S; Dontsop M; Mben JM; Koulla-Shiro S; Peytavin G; Spire B; Delaporte E; Laurent C;
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):355-64. PubMed ID: 26181708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa.
    Le Roux KW; Davis EC; Gaunt CB; Young C; Koussa M; Harris C; Rotheram-Borus MJ
    AIDS Patient Care STDS; 2019 Nov; 33(11):466-472. PubMed ID: 31682167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa.
    Brennan AT; Maskew M; Sanne I; Fox MP
    J Int AIDS Soc; 2010 Dec; 13():49. PubMed ID: 21134297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.
    Bijker R; Jiamsakul A; Kityo C; Kiertiburanakul S; Siwale M; Phanuphak P; Akanmu S; Chaiwarith R; Wit FW; Sim BL; Boender TS; Ditangco R; Rinke De Wit TF; Sohn AH; Hamers RL
    J Int AIDS Soc; 2017 Mar; 20(1):21218. PubMed ID: 28362063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study.
    Unge C; Södergård B; Marrone G; Thorson A; Lukhwaro A; Carter J; Ilako F; Ekström AM
    PLoS One; 2010 Oct; 5(10):e13613. PubMed ID: 21049045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the Effect of COVID-19 Pandemic Restrictions on Self-reported Antiretroviral Therapy Use and Late Refill Visits Among People Living With HIV in Rural South Africa.
    Tseng AS; Mugwanya KK; Szpiro AA; van Heerden A; Ntinga X; Schaafsma TT; Barnabas RV
    J Acquir Immune Defic Syndr; 2024 Aug; 96(4):318-325. PubMed ID: 38916425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
    Nachega JB; Hislop M; Nguyen H; Dowdy DW; Chaisson RE; Regensberg L; Cotton M; Maartens G
    J Acquir Immune Defic Syndr; 2009 May; 51(1):65-71. PubMed ID: 19282780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social support, disclosure and stigma and the association with non-adherence in the six months after antiretroviral therapy initiation among a cohort of HIV-positive adults in rural KwaZulu-Natal, South Africa
    George S; McGrath N
    AIDS Care; 2019 Jul; 31(7):875-884. PubMed ID: 30472889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
    Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Velloza J; Kemp CG; Aunon FM; Ramaiya MK; Creegan E; Simoni JM
    AIDS Behav; 2020 Jun; 24(6):1727-1742. PubMed ID: 31673913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.
    Haberer JE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Siedner MJ; Matthews LT; Tsai AC; Katz IT; Bell K; Kembabazi A; Mugisha S; Kibirige V; Cross A; Kelly N; Hedt-Gauthier B; Bangsberg DR
    J Int AIDS Soc; 2019 Feb; 22(2):e25232. PubMed ID: 30746898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
    Fatti G; Mothibi E; Shaikh N; Grimwood A
    AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes.
    Moorhouse M; Maartens G; Venter WDF; Moosa MY; Steegen K; Jamaloodien K; Fox MP; Conradie F
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):73-78. PubMed ID: 30334876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
    Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
    Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.